Equity Overview
Price & Market Data
Price: $0.943
Daily Change: -$0.0867 / 9.19%
Daily Range: $0.935 - $1.05
Market Cap: $3,799,446
Daily Volume: 164,147
Performance Metrics
1 Week: -8.45%
1 Month: 5.48%
3 Months: -31.66%
6 Months: -49.98%
1 Year: -66.42%
YTD: -70.50%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.